scholarly article | Q13442814 |
P50 | author | Laurent Emmanuel Dardenne | Q59687511 |
Vanessa Vc Sinatti | Q93185204 | ||
P2093 | author name string | Ana Carolina Guimarães | |
Joao Hm Da Silva | |||
Luiz Phillippe R Baptista | |||
P2860 | cites work | An analysis of FDA-approved drugs: natural products and their derivatives. | Q53629544 |
3‐Mercaptopicolinic acid, a preferential inhibitor of the cytosolic phosphoenolpyruvate carboxykinase | Q67384435 | ||
Prediction of drug absorption using multivariate statistics | Q73126791 | ||
Cancer Cells Hijack Gluconeogenic Enzymes to Fuel Cell Growth | Q86756788 | ||
Crystal structure of human cytosolic phosphoenolpyruvate carboxykinase reveals a new GTP-binding site | Q24292320 | ||
MolProbity: all-atom structure validation for macromolecular crystallography | Q24649111 | ||
Very fast prediction and rationalization of pKa values for protein-ligand complexes | Q27144110 | ||
Structures of rat cytosolic PEPCK: insight into the mechanism of phosphorylation and decarboxylation of oxaloacetic acid | Q27647056 | ||
Differential inhibition of cytosolic PEPCK by substrate analogues. Kinetic and structural characterization of inhibitor recognition | Q27649538 | ||
ZINC--a free database of commercially available compounds for virtual screening | Q27656255 | ||
The Ω-Loop Lid Domain of Phosphoenolpyruvate Carboxykinase Is Essential for Catalytic Function | Q27674982 | ||
Inhibition and Allosteric Regulation of Monomeric Phosphoenolpyruvate Carboxykinase by 3-Mercaptopicolinic Acid | Q27702033 | ||
Three-dimensional structure of rat acid phosphatase in complex with L(+)-tartrate | Q27732059 | ||
Crystal structure of Escherichia coli phosphoenolpyruvate carboxykinase: a new structural family with the P-loop nucleoside triphosphate hydrolase fold | Q27732635 | ||
Structural origins of L(+)-tartrate inhibition of human prostatic acid phosphatase | Q27765889 | ||
Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings | Q27861111 | ||
ClassyFire: automated chemical classification with a comprehensive, computable taxonomy | Q27902281 | ||
PubChem Substance and Compound databases | Q27942588 | ||
PCK2 activation mediates an adaptive response to glucose depletion in lung cancer | Q28235954 | ||
Mitochondrial phosphoenolpyruvate carboxykinase (PEPCK-M) is a pro-survival, endoplasmic reticulum (ER) stress response gene involved in tumor cell adaptation to nutrient availability | Q28242891 | ||
Structural insights into the mechanism of PEPCK catalysis | Q28250327 | ||
Assessment of protein models with three-dimensional profiles | Q28283805 | ||
Inhibition of Pig Phosphoenolpyruvate Carboxykinase Isoenzymes by 3-Mercaptopicolinic Acid and Novel Inhibitors | Q28552510 | ||
Hypoxia--a key regulatory factor in tumour growth | Q29547318 | ||
Statistical potential for assessment and prediction of protein structures | Q29615145 | ||
Verification of protein structures: patterns of nonbonded atomic interactions | Q29615613 | ||
Charting biologically relevant chemical space: a structural classification of natural products (SCONP) | Q30351855 | ||
Global, regional, and national life expectancy, all-cause mortality, and cause-specific mortality for 249 causes of death, 1980-2015: a systematic analysis for the Global Burden of Disease Study 2015. | Q30353189 | ||
PrediSi: prediction of signal peptides and their cleavage positions | Q31081611 | ||
Interactive exploration of chemical space with Scaffold Hunter | Q33475598 | ||
Pharmer: efficient and exact pharmacophore search | Q33909006 | ||
Screening of well-established drugs targeting cancer metabolism: reproducibility of the efficacy of a highly effective drug combination in mice | Q33927565 | ||
Molecular properties that influence the oral bioavailability of drug candidates | Q34130727 | ||
DecoyFinder: an easy-to-use python GUI application for building target-specific decoy sets. | Q34249296 | ||
Metabolic determinants of cancer cell sensitivity to glucose limitation and biguanides. | Q34412152 | ||
Computer-based de novo design of drug-like molecules | Q34438895 | ||
Chemistry and biochemistry of (-)-hydroxycitric acid from Garcinia. | Q34469262 | ||
PCK1 and PCK2 as candidate diabetes and obesity genes | Q34654770 | ||
FAF-Drugs3: a web server for compound property calculation and chemical library design. | Q35604907 | ||
Cutting the cost of drug development? | Q35732868 | ||
ZINCPharmer: pharmacophore search of the ZINC database | Q36088378 | ||
PEPCK Coordinates the Regulation of Central Carbon Metabolism to Promote Cancer Cell Growth | Q36307664 | ||
Inhibitory effect of traditional oriental medicine-derived monoamine oxidase B inhibitor on radioresistance of non-small cell lung cancer | Q36611260 | ||
What is the metabolic role of phosphoenolpyruvate carboxykinase? | Q37447862 | ||
Structural insights into the mechanism of phosphoenolpyruvate carboxykinase catalysis | Q37564716 | ||
Understanding the Effectiveness of Natural Compound Mixtures in Cancer through Their Molecular Mode of Action. | Q37729331 | ||
Molecular aptamers for drug delivery | Q37912756 | ||
Non-small-cell lung cancers: a heterogeneous set of diseases | Q38233321 | ||
Mitochondrial Phosphoenolpyruvate Carboxykinase Regulates Metabolic Adaptation and Enables Glucose-Independent Tumor Growth. | Q38827417 | ||
Counting on natural products for drug design | Q38843130 | ||
systemsDock: a web server for network pharmacology-based prediction and analysis | Q40774775 | ||
Comparative Protein Structure Modeling Using MODELLER. | Q41144462 | ||
Directory of useful decoys, enhanced (DUD-E): better ligands and decoys for better benchmarking | Q42251037 | ||
P275 | copyright license | Creative Commons Attribution-NonCommercial 3.0 Unported | Q18810331 |
P6216 | copyright status | copyrighted | Q50423863 |
P304 | page(s) | 15-32 | |
P577 | publication date | 2019-08-07 | |
P1433 | published in | Advances and Applications in Bioinformatics and Chemistry | Q4686376 |
P1476 | title | Computational evaluation of natural compounds as potential inhibitors of human PEPCK-M: an alternative for lung cancer therapy | |
P478 | volume | 12 |
Search more.